<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03487224</url>
  </required_header>
  <id_info>
    <org_study_id>42327</org_study_id>
    <nct_id>NCT03487224</nct_id>
  </id_info>
  <brief_title>Neural Mechanisms of Decision Making in Hoarding Disorder</brief_title>
  <acronym>LOSS</acronym>
  <official_title>Neural Mechanisms of Decision Making in Hoarding Disorder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to understand the neural mechanisms of decision making in
      hoarding disorder.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hoarding disorder is a common and disabling disorder that represents a significant public
      health problem. This study aims to build on current research on decision making by examining
      these processes in hoarding disorder.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">July 8, 2018</start_date>
  <completion_date type="Anticipated">May 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">May 30, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>BOLD signal</measure>
    <time_frame>up to 90 minutes</time_frame>
    <description>BOLD signal derived from fMRI</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Hoarding Disorder</condition>
  <arm_group>
    <arm_group_label>Hoarding Disorder</arm_group_label>
    <description>Adults diagnosed with Hoarding Disorder</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy Controls</arm_group_label>
    <description>Adults without mental illness</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MRI with fMRI frequency</intervention_name>
    <description>Functional magnetic resonance imaging or fMRI measures brain activity by detecting changes in blood flow. Participants will do cognitive tasks during fMRI.</description>
    <arm_group_label>Healthy Controls</arm_group_label>
    <arm_group_label>Hoarding Disorder</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Individuals with Hoarding Disorder and Healthy Participants
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Identify inclusion criteria.

        Inclusion criteria for participants diagnosed with HD:

          1. ages 18-70

          2. primary diagnosis of hoarding disorder

          3. sufficient severity of hoarding symptoms

          4. stable on psychotropic medications for 1 month prior to study enrollment

          5. capacity to provide informed consent

          6. ability to tolerate clinical study procedures

        Inclusion criteria for healthy control participants:

          1. ages 18-70

          2. capacity to provide informed consent

        Identify exclusion criteria.

        Exclusion criteria for participants with HD:

          1. psychiatric or medical conditions that make participation unsafe

          2. pregnant or nursing females

          3. concurrent use of any medications that might increase the risk of participation (e.g.
             drug interactions)

          4. presence of metallic device or dental braces

        Exclusion criteria for healthy control participants:

          1. any current or lifetime psychiatric diagnosis

          2. current or past use of psychotropic medication

          3. pregnant or nursing females

          4. major medical or neurological problem

          5. presence of metallic device or dental braces
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://med.stanford.edu/profiles/carolyn-rodriguez?tab=bio</url>
    <description>Stanford Medicine Faculty Page</description>
  </link>
  <link>
    <url>http://med.stanford.edu/rodriguezlab/</url>
    <description>Rodriguez Lab Website</description>
  </link>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>March 27, 2018</study_first_submitted>
  <study_first_submitted_qc>March 27, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 3, 2018</study_first_posted>
  <last_update_submitted>June 25, 2020</last_update_submitted>
  <last_update_submitted_qc>June 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 29, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Carolyn Rodriguez</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Hoarding Disorder</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Hoarding Disorder</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

